Original news and analysis on international IP policy
Recent customs seizures by some European Union members of Indian-made generic drugs en route to Latin America have caused uproar amongst development NGOs. But their claims are not only wide of the mark but dangerous, say Philip Stevens and Julian Harris.
The issue of counterfeit and substandard medicines is again not on the agenda of the World Health Organization Executive Board meeting in January, though sources say member states are being consulted about the issue by the secretariat.
The World Health Organization secretariat has released its report to the executive board meeting on pandemic influenza preparedness. A framework for handling outbreaks of potentially pandemic influenza was approved in May this year, but outstanding – and critical - elements of the framework remained unfinished.
Implementation of a United Nations-related patent pool initiative that independent reviewers say could save millions of lives (and dollars) is set to be approved next week by the initiative’s board, though some observers fear resistance from strong patent beneficiaries, such as the foundation run by Microsoft founder Bill Gates. A confidential report on the initiative prepared for board approval is expected to show multiple benefits to implementation of the pool, but also some concerns, according to informed sources.
Le groupe d’experts sur les financements innovants pour la recherche et le développement, réuni sous les auspices de l'Organisation mondiale de la Santé (OMS), a tenu sa troisième et dernière réunion du 30 novembre au 2 décembre. Le rapport de ce comité très secret devrait être communiqué aux Etats membres dans les semaines qui viennent, selon certaines sources.
Confidential documents related to the World Health Organization Expert Working Group on innovative financing for research and development surfaced today, revealing the group’s thinking as well as pharmaceutical industry thinking about the WHO process. The documents immediately raised concern about possible undue access to the process by industry, but the WHO told Intellectual Property Watch the industry group was not supposed to have them.
Daniele Dionisio argues some perspectives on health and IP might change now that controversial practices at the WTO, World Bank and IMF are increasingly under pressure, and that new government policy choices and actors on the world chessboard are emerging.
An expert working group on innovative financing for research and development, meeting under the auspices of the World Health Organization, held its third and final meeting last week, with a report from the secretive group expected to be released to member states in the coming weeks, according to sources.
European Union governments have unanimously approved a roadmap for a single European patent regime. The system is seen as key to making patenting less expensive and more efficient for European inventors, but the devil, as always, is in the details, stakeholders say.
NAIROBI - At the headquarters of UNITAID and other groups seeking to boost access to HIV/AIDS medicine, the notion of a patent pool where drug companies would combine their intellectual property is seen as an important way to drive down drug costs.
In the Kenyan capital Nairobi, home of AIDS activist Nelson Otwoma, the patent pool is a matter of life and death.